What Clinical Endpoints And Safety Precautions Should Laser Operators Monitor During Resurfacing Treatments To Prevent Scarring And Dyschromia? Key Strategies For Safe Outcomes

During laser resurfacing, operators should monitor tissue color, desiccation, erythema, treatment overlap, and cumulative passes. The critical ablative endpoint is a faint yellow-white “chamois” appearance, which indicates penetration into the reticular dermis; further passes at that site substantially increase the risk of permanent scarring. Prevention also depends on test spots, individualized fluence, strict UV management, and early recognition of excessive thermal injury.

Core takeaway: Stop treatment when the intended endpoint is reached—especially when tissue becomes chamois-colored, markedly desiccated, or the target rhytid has disappeared. Scarring and dyschromia are usually preventable by controlling thermal dose, avoiding overlap and pulse stacking, protecting vulnerable anatomy, and managing pigment-related risk before and after treatment.

Recognize the Relevant Clinical Endpoints

Use tissue color as a depth indicator

During ablative CO₂ or Er:YAG resurfacing, tissue color can help estimate penetration depth:

Pink: Primarily epidermal treatment.
Gray: Extension into the papillary dermis.
Yellow-white or chamois-colored: Entry into the reticular dermis.

The chamois endpoint is a stop signal, not a target to exceed. Deeper treatment can destroy dermal appendages that support re-epithelialization and substantially increase the risk of permanent scarring.

Stop when the treatment goal is achieved

Treatment should also stop when the target rhytid has disappeared or when visible tissue desiccation develops. Continuing to treat an area after the clinical objective has been reached adds thermal injury without necessarily improving the result.

Monitor erythema and epidermal graying

Marked erythema, gray discoloration, or obvious epidermal damage indicates a high tissue response. The operator should reassess fluence, pulse duration, pass count, and cooling immediately, and should stop treatment in an area that is showing excessive injury.

Control Cumulative Thermal Injury

Prevent overlapping scan patterns

With automated scanners, adjacent treatment patterns should be aligned precisely without overlap. Overlapping scans increase local energy density and can produce prolonged erythema, delayed healing, pigmentary alteration, or scarring.

Avoid pulse stacking and excessive passes

Multiple passes over the same area can create residual thermal necrosis even when each individual pass appears acceptable. Pass counts should be limited according to both the device protocol and the thickness and vascularity of the anatomic site.

Thin eyelid and neck skin generally require more conservative treatment than thicker cheek or perioral skin. The anterior neck, mandible, infraorbital region, surgical flaps, and other compromised areas deserve particular caution.

Clear debris between passes

Vaporized tissue and charred debris should be gently removed between passes with sterile saline-moistened gauze or a moist sponge, followed by dry gauze when appropriate. This maintains visibility of the tissue endpoint and reduces the risk of inadvertently stacking energy over an inadequately assessed area.

Use cooling appropriately

Inadequate epidermal cooling increases the risk of excessive thermal injury. Cooling should be consistent with the device, treatment depth, and clinical protocol, while avoiding practices that obscure tissue color or prevent accurate endpoint assessment.

Establish Patient-Specific Safety Limits Before Treatment

Perform test spots

A test spot of approximately 2 × 2 cm can demonstrate the patient’s acute inflammatory response and provide information about dyschromia risk. Where appropriate, multiple test spots using different fluences or pulse durations can help establish a safer working range before full-area treatment.

A test spot does not eliminate risk, because full-face treatment introduces greater cumulative thermal and inflammatory exposure. It should be treated as a risk-reduction step rather than a guarantee of safety.

Screen for elevated scarring or pigment risk

Pre-treatment assessment should include:

History of keloids or hypertrophic scars.
Recent or current isotretinoin or systemic retinoid exposure, according to applicable clinical guidance.
Prior radiation therapy or other conditions that may impair healing.
Active infection, inflammation, dermatitis, or compromised skin-barrier function.
Recent tanning or substantial sun exposure.
Baseline tendency toward post-inflammatory hyperpigmentation or hypopigmentation.

Patients with relevant risk factors may require modified parameters, delayed treatment, specialist evaluation, or an alternative procedure.

Account for skin type and baseline pigmentation

Elevated epidermal melanin can alter laser energy absorption and increase the risk of unwanted pigmentary change. Operators should avoid treating recently tanned skin and should select conservative, individualized settings rather than relying solely on a standard protocol.

Reduce the Risk of Dyschromia

Manage ultraviolet exposure before treatment

Patients should avoid tanning and unnecessary sun exposure before resurfacing. Treatment of recently tanned skin can increase unpredictable energy absorption and may worsen the risk of post-inflammatory pigment alteration.

Enforce strict postoperative UV protection

Treated skin should be protected from ultraviolet exposure for several weeks after the procedure, following the treating clinician’s protocol. Sun avoidance, protective clothing, and appropriate broad-spectrum sunscreen are central to reducing post-inflammatory hyperpigmentation and other dyschromias.

Distinguish expected inflammation from excessive injury

Transient erythema is expected after resurfacing, but marked, persistent, or worsening erythema may indicate excessive thermal injury, infection, or delayed healing. The patient should receive clear instructions on when to report increasing pain, drainage, blistering, tissue darkening, or progressive redness.

Understand the Trade-offs

More energy is not always a better treatment

Higher fluence, deeper ablation, greater spot density, and additional passes may improve resurfacing intensity but also narrow the margin of safety. Once the desired clinical endpoint is reached, additional treatment generally increases risk more reliably than benefit.

Aggressive fractional treatment can become confluent

Fractional devices create microscopic treatment zones, but excessive pulse energy, depth, or spot density can cause those zones to merge into a near-continuous defect. This can lead to delayed healing and hypertrophic scarring.

Infection and scratching can worsen scarring

Scarring is not caused only by the laser settings. Post-procedure infection, trauma, picking, or scratching can disrupt healing and convert a controlled injury into a more significant wound.

Patients should receive practical wound-care instructions and should be evaluated promptly for suspected infection or abnormal healing. Prophylactic medications should follow the specific procedure, patient risk profile, and local clinical protocol rather than being applied indiscriminately.

Visual endpoints have limitations

Skin color is useful but not infallible. Lighting, debris, skin tone, device type, previous passes, and operator experience can affect interpretation, so endpoint assessment must be combined with accurate parameter records, anatomic judgment, and continuous monitoring of the patient’s response.

How to Apply This to a Resurfacing Procedure

Use a conservative, endpoint-driven protocol and document the settings, passes, anatomic zones, test-spot response, and post-treatment instructions.

If your primary focus is preventing scarring: Stop at the intended endpoint—especially the chamois appearance—while avoiding scan overlap, pulse stacking, excessive passes, and aggressive settings on thin or compromised skin.
If your primary focus is preventing dyschromia: Treat only appropriately prepared, untanned skin, use a test spot when indicated, individualize parameters, and enforce strict postoperative UV protection.
If your primary focus is procedural consistency: Remove debris between passes, monitor tissue color and erythema continuously, and record energy, pulse duration, density, cooling, and pass count by anatomic region.
If your primary focus is early complication detection: Arrange follow-up and instruct patients to report worsening erythema, pain, drainage, blistering, tissue darkening, delayed re-epithelialization, or early skin thickening.

Safe resurfacing is achieved by treating the clinical endpoint—not by maximizing the number of passes or the amount of energy delivered.

Summary Table:

Endpoint / Safety Measure	Description	Clinical Significance
Tissue color	Pink: epidermal; Gray: papillary dermis; Yellow-white (chamois): reticular dermis	Chamois color indicates maximum safe depth; further treatment increases scarring risk
Desiccation	Visible tissue dehydration	Stop treatment when desiccation occurs to prevent excessive thermal injury
Erythema and graying	Marked redness or gray discoloration	Signs of excessive tissue response; reassess and stop treatment in that area
Overlap prevention	Avoid overlapping scan patterns	Prevents increased local energy density and reduces risk of scarring
Pulse stacking avoidance	Limit multiple passes over same area	Minimizes cumulative thermal necrosis and delayed healing
UV protection	Pre-op sun avoidance, post-op strict protection	Reduces risk of post-inflammatory hyperpigmentation and dyschromia
Test spots	2x2 cm spot before full treatment	Assess individual response and dyschromia risk
Cooling	Appropriate epidermal cooling	Prevents thermal damage while maintaining visibility of tissue endpoint
Recognizing infection	Monitor for signs of infection	Early detection prevents scarring and abnormal healing

Elevate your practice with BELIS's cutting-edge laser and aesthetic devices. Our portfolio includes advanced CO2 fractional, Erbium, and Nd:YAG systems designed for precise resurfacing and safety. With dedicated OEM/ODM support, international certifications, and reliable supply, we empower clinics and medispas to deliver exceptional results. Contact BELIS today to learn how we can help you achieve superior patient outcomes and expand your business. Get in touch with us now!